Manage New Warnings About Clarithromycin and Cardiovascular Risk

You may see drug-disease alerts pop up about an increased risk of CV events or death with clarithromycin...due to a new FDA warning.

The focus is on patients with coronary artery disease (CAD).

Macrolide antibiotics...clarithromycin, erythromycin, and azithromycin...already have warnings about QT prolongation and torsades.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote